Spyre Therapeutics Stock Price Prediction
| SYRE Stock | 18.04 0.01 0.06% |
Momentum 32
Sell Stretched
Oversold | Overbought |
Quarterly Earnings Growth (1.00) | EPS Estimate Next Quarter (0.79) | EPS Estimate Current Year (3.48) | EPS Estimate Next Year (3.74) | Wall Street Target Price 58.625 |
Using Spyre Therapeutics hype-based prediction, you can estimate the value of Spyre Therapeutics from the perspective of Spyre Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Spyre Therapeutics using Spyre Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Spyre using crowd psychology based on the activity and movement of Spyre Therapeutics' stock price.
Spyre Therapeutics Implied Volatility | 1.38 |
Spyre Therapeutics' implied volatility exposes the market's sentiment of Spyre Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Spyre Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Spyre Therapeutics stock will not fluctuate a lot when Spyre Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Spyre Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Spyre because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Spyre Therapeutics after-hype prediction price | USD 18.04 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Spyre contract
Based on the Rule 16, the options market is currently suggesting that Spyre Therapeutics will have an average daily up or down price movement of about 0.0862% per day over the life of the 2025-06-20 option contract. With Spyre Therapeutics trading at USD 18.04, that is roughly USD 0.0156 . If you think that the market is fully incorporating Spyre Therapeutics' daily price movement you should consider acquiring Spyre Therapeutics options at the current volatility level of 1.38%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Spyre |
Spyre Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Spyre Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Spyre Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Spyre Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Spyre Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Spyre Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Spyre Therapeutics' historical news coverage. Spyre Therapeutics' after-hype downside and upside margins for the prediction period are 14.24 and 21.84, respectively. We have considered Spyre Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Spyre Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Spyre Therapeutics is based on 3 months time horizon.
Spyre Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Spyre Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Spyre Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Spyre Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.42 | 3.77 | 0.05 | 0.06 | 7 Events / Month | 4 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
18.04 | 18.04 | 0.00 |
|
Spyre Therapeutics Hype Timeline
Spyre Therapeutics is at this time traded for 18.04. The entity has historical hype elasticity of -0.05, and average elasticity to hype of competition of -0.06. Spyre is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.42%. %. The volatility of related hype on Spyre Therapeutics is about 2562.14%, with the expected price after the next announcement by competition of 17.98. About 91.0% of the company shares are owned by institutional investors. The book value of Spyre Therapeutics was at this time reported as 6.01. The company recorded a loss per share of 3.18. Spyre Therapeutics had not issued any dividends in recent years. The entity had 1:25 split on the 8th of September 2023. Given the investment horizon of 90 days the next projected press release will be in about 7 days. Check out Spyre Therapeutics Basic Forecasting Models to cross-verify your projections.Spyre Therapeutics Related Hype Analysis
Having access to credible news sources related to Spyre Therapeutics' direct competition is more important than ever and may enhance your ability to predict Spyre Therapeutics' future price movements. Getting to know how Spyre Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Spyre Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PKE | Park Electrochemical | 0.03 | 9 per month | 0.00 | (0.02) | 2.20 | (2.98) | 7.97 | |
| HNI | HNI Corp | (0.35) | 9 per month | 0.00 | (0.15) | 2.84 | (3.52) | 8.91 | |
| TCI | Transcontinental Realty Investors | (0.08) | 9 per month | 0.00 | 0.04 | 4.17 | (3.53) | 12.24 | |
| EGP | EastGroup Properties | (0.42) | 9 per month | 1.25 | 0.16 | 1.89 | (1.94) | 7.67 | |
| GFF | Griffon | (1.31) | 10 per month | 0.00 | (0.06) | 2.22 | (3.19) | 12.51 | |
| EMR | Emerson Electric | 1.10 | 12 per month | 0.00 | (0.07) | 2.13 | (2.68) | 9.68 | |
| CTYMF | Catalyst Metals Limited | 0.00 | 0 per month | 2.94 | 0.22 | 9.00 | (6.25) | 27.62 |
Spyre Therapeutics Additional Predictive Modules
Most predictive techniques to examine Spyre price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Spyre using various technical indicators. When you analyze Spyre charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Spyre Therapeutics Predictive Indicators
The successful prediction of Spyre Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Spyre Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Spyre Therapeutics based on analysis of Spyre Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Spyre Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Spyre Therapeutics's related companies. | 2022 | 2024 | 2025 (projected) | Days Sales Outstanding | 58.77 | 67.59 | 107.38 | PTB Ratio | 0.75 | 16.83 | 10.84 |
Story Coverage note for Spyre Therapeutics
The number of cover stories for Spyre Therapeutics depends on current market conditions and Spyre Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Spyre Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Spyre Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Spyre Therapeutics Short Properties
Spyre Therapeutics' future price predictability will typically decrease when Spyre Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Spyre Therapeutics often depends not only on the future outlook of the potential Spyre Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Spyre Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 374.4 M | |
| Cash And Short Term Investments | 603.1 M |
Complementary Tools for Spyre Stock analysis
When running Spyre Therapeutics' price analysis, check to measure Spyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spyre Therapeutics is operating at the current time. Most of Spyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Spyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spyre Therapeutics' price. Additionally, you may evaluate how the addition of Spyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |